DarioHealth Corp. Banner Image

DarioHealth Corp.

  • Ticker DRIO
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
DarioHealth Corp. Logo Image
  • 51-200 Employees
  • Based in New York City, New York
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, they empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Their cross-functionalMore team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.
4.8 / 5.0 (128)

DarioHealth Corp. reports have an aggregate usefulness score of 4.8 based on 128 reviews.

DarioHealth Corp.

Most Recent Annual Report

DarioHealth Corp.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

DarioHealth Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!